Insider · CIK 0001845650
Rohit Nanani
Files at IRAB (Iris Acquisition Corp II). First filing -, latest -.
Rohit Nanani files SEC Form 4 as director at IRAB (Iris Acquisition Corp II). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rohit Nanani has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | IRAB Iris Acquisition Corp II | POpen-market purchase Class A ordinary sharesindirect: See Footnote | +251,000 | - | - | 251,000 | Feb 5, 2026 |
| Feb 4, 2026 | IRAB Iris Acquisition Corp II | DDisposition to issuer Class B Ordinary Sharesderivativeindirect: See Footnote | -133,333 | - | - | 5,616,667 | Feb 5, 2026 |
| Feb 4, 2026 | IRAB Iris Acquisition Corp II | POpen-market purchase Warrants to purchase Class A ordinary sharesderivativeindirect: See Footnote | +125,500 | - | - | 125,500 | Feb 5, 2026 |
Questions about Rohit Nanani
Answered from the filings on this page, as of the latest one.
Is Rohit Nanani buying or selling?
Rohit Nanani has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rohit Nanani's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rohit Nanani has 0.
Where does Rohit Nanani file Form 4?
Rohit Nanani has filed Form 4 at IRAB (Iris Acquisition Corp II). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.